| Predicting kinase inhibitors using bioactivity matrix derived informer sets H Zhang, SS Ericksen, C Lee, GE Ananiev, N Wlodarchak, P Yu, ... PLoS computational biology 15 (8), e1006813, 2019 | 12 | 2019 |
| Molecular characterization of hypoxanthine guanine phosphoribosyltransferase mutant T cells in human blood: The concept of surrogate selection for immunologically relevant cells NA Kaitz, CL Zuleger, P Yu, MA Newton, RJ Albertini, MR Albertini Mutation Research/Reviews in Mutation Research 789, 108414, 2022 | 3 | 2022 |
| Bayes optimal informer sets for early‐stage drug discovery P Yu, S Ericksen, A Gitter, MA Newton Biometrics 79 (2), 642-654, 2023 | 2 | 2023 |
| Surrogate selection oversamples expanded T cell clonotypes P Yu, Y Lian, CL Zuleger, RJ Albertini, MR Albertini, MA Newton bioRxiv, 2023 | | 2023 |
| Bayes Optimal Informer Sets for Drug Discovery and Surrogate Selection of T-cell Clonotypes P Yu The University of Wisconsin-Madison, 2022 | | 2022 |
